Search Login Register

trastuzumab (Herceptin) Summary

1669 relevant articles (277 outcomes, 422 trials/studies) found for this Drug

Description: a HER2 antibody that lengthens remission time in metastatic breast cancer

Also Known As: Herceptin; Genentech brand of trastuzumab; Hoffman-La Roche brand of trastuzumab; Roche brand of trastuzumab

Key Diseases for which trastuzumab is Relevant

  1. Breast Neoplasms (Breast Cancer) : 197 outcomes 290 studies in 1207 results
  2. Neoplasms (Cancer) : 62 outcomes 94 studies in 538 results
  3. Neoplasm Metastasis (Metastasis) : 17 outcomes 9 studies in 99 results
  4. Carcinoma (Carcinomatosis) : 13 outcomes 19 studies in 131 results
  5. Disease Progression : 8 outcomes 16 studies in 79 results
Show All >>

Drugs Related to trastuzumab

  1. trastuzumab (Herceptin)
  2. Paclitaxel (Taxol)
  3. docetaxel (Taxotere)
  4. Epidermal Growth Factor Receptor (EGF Receptor)
  5. gemcitabine
  6. taxane
  7. capecitabine (Xeloda)
  8. vinorelbine (Navelbine)
  9. Cyclophosphamide (Cytoxan)
  10. gefitinib (Iressa)
Show All >>

Therapies Related to trastuzumab

  1. Drug Therapy (Chemotherapy)
  2. Adjuvant Chemotherapy
  3. Aftercare (After-Treatment)
  4. Heterologous Transplantation (Xenotransplantation)
  5. Neoadjuvant Therapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.